Start-up
CTN 303: Decentralizing PrEP
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses
Learn MoreStart-up
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses
Learn MoreOngoing
Indigenous, participatory evaluation and assessment of a culturally-grounded and arts-informed intervention for HIV-positive Aboriginal women
Learn MoreStart-up
Contextual Analysis of Urban and Rural Programs and Supports for First Nations and Métis People Living with HIV and other STBBIs
Learn MoreReporting
Development of a Rural Model (DRUM) for Integrated Shared Care in First Nation and Métis Communities
Learn MoreOngoing
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
Learn MoreCompleted
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
Learn MoreReporting
A proof-of-concept study to assess the effect of recombinant human growth hormone on the size of the replication-competent viral reservoir in HIV-infected individuals on suppressive ART
Learn MoreCompleted
HIV Stigma Reduction Intervention with African, Caribbean and Black Faith Communities in Ontario
Learn MoreReporting
Longitudinal Analysis of HIV Genetic Diversification under Antiretroviral therapy (LAHGDA)
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.